Published in Mental Health Business Week, January 2nd, 2010
"Muller cells derived from COX-2-null mice were treated with increasing concentrations of the EP4 agonist PGE(1)-OH, and wild-type Muller cells were treated with increasing concentrations of the EP4 antagonist L-161982; VEGF production was assessed....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.